Cas:885274-35-1 2-(3-Bromophenyl)-1,3-oxazole manufacturer & supplier

We serve Chemical Name:2-(3-Bromophenyl)-1,3-oxazole CAS:885274-35-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3-Bromophenyl)-1,3-oxazole

Chemical Name:2-(3-Bromophenyl)-1,3-oxazole
CAS.NO:885274-35-1
Synonyms:Oxazole,2-(3-bromophenyl);2-(2,4-DIFLUOROPHENOXY)PROPANOHYDRAZIDE;2-(3-BROMO-PHENYL)-OXAZOLE
Molecular Formula:C9H6BrNO
Molecular Weight:224.05400
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.03000
Exact Mass:222.96300
LogP:3.10410

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Oxazole,2-(3-bromophenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3-BROMO-PHENYL)-OXAZOLE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Oxazole,2-(3-bromophenyl) Use and application,Oxazole,2-(3-bromophenyl) technical grade,usp/ep/jp grade.


Related News: United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong. 2-(3-Bromophenyl)-1,3-oxazole manufacturer Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. 2-(3-Bromophenyl)-1,3-oxazole supplier Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 2-(3-Bromophenyl)-1,3-oxazole vendor United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong. 2-(3-Bromophenyl)-1,3-oxazole factory With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.